Boston Bio Systems Ltd Share Price

Boston Bio
Small Cap | Healthcare
₹ 6.93 0.33 (5%)
Last updated: 26-Dec-2025 , 16:01:40

Boston Bio Systems Ltd Live Price Chart

Low: ₹6.6 High: 6.93

Boston Bio Systems Ltd Technicals

Current Price
₹ 6.93 0.33 (5%)
EMASMA
20 Day ₹ 6.944
50 Day ₹ 7.319
100 Day ₹ 7.758
200 Day ₹ 8.719
20 Day ₹ 6.967
50 Day ₹ 7.443
100 Day ₹ 7.775
200 Day ₹ 8.774

Boston Bio Systems Ltd Performance

Previous Close ₹ 6.6
High ₹ 6.93
Volume 328
52W Range ₹ 6.36 - ₹ 22
Open ₹ 6.6
Low ₹ 6.6
Market Cap 4.87 Cr

Boston Bio Systems Ltd Fundamentals

ROCE -3.030
P/E Ratio -10.000
P/B Ratio 0.770
Industry P/E 0.770
Debt to Equity 79.482
ROE -7.734
EPS -0.660
Dividend Yield 0.000
Book Value 8.545
Face Value 10.000

Boston Bio Systems Ltd Financials

Particulars Y202503 Y202403 Y202303 Y202203 Y201803
Total Revenue 0.1925 0 0 0 0.6996833
Total Expenses 0.7398 0.1407 0.0022 0.00188 0.6993239
Profit After Tax -0.5473 -0.1407 -0.0022 -0.00188 0.0003476

Boston Bio Systems Ltd Shareholding Pattern

Promoter Holdings 2.143 %
FIIs 0.000 %
DIIs 0.000 %
MutualFund 0.000 %
Retail 85.213 %
Others - 12.644 %

About Boston Bio Systems Ltd

History of Boston Bio Systems Ltd

Boston Bio Systems Limited was incorporated on April 17, 1995. Initially, Company was engaged in share broking. Presently, it trades in medical equipment, testing kits and instruments. The Company specialize in jobworking for herbal and health-related products, partnering with businesses to bring their formulations and ideas to life. With a strong foundation in natural wellness, Company is providing high-quality, custom solutions to the growing demand for herbal products and health supplements. Apart from these, Company provide custom buffers to keep the projects running seamlessly. It customized manufacturing of herbal supplements, wellness products, and natural remedies. Private labeling for businesses are looking to market their own brand of herbal products. The Company also work fo ...

Similar Stocks

Company 52 Week Market Price P/E Ratio
Aegis Logistics Ltd ₹ 609.85 - ₹ 1037 723.25 48.28
Trent Ltd ₹ 3930.1 - ₹ 7493.05 4283.8 90.08
Oswal Agro Mills Ltd ₹ 55 - ₹ 110.8 57.1 6.61
Standard Industries Ltd ₹ 15.6 - ₹ 28.79 15.97 -5.62
Dhunseri Ventures Ltd ₹ 270 - ₹ 402 285.6 56.64

FAQs on Boston Bio Systems Ltd

1. Can I buy Boston Bio Systems Ltd from PL Capital? ›

Yes, you can invest in Boston Bio Systems Ltd shares directly through PL Capital. Our platform provides a seamless and secure way to buy, hold, and track Boston Bio Systems Ltd stock along with other leading companies listed on the NSE and BSE. Simply open a Demat and trading account with PL Capital, and you’ll be able to trade Boston Bio Systems Ltd as well as diversify your portfolio across equities, mutual funds, IPOs, and more.

2. Does Boston Bio Systems Ltd pay dividends? ›

Boston Bio Systems Ltd does not currently pay dividends. Investors in this case primarily benefit from capital appreciation, where the value of the stock may rise over time depending on business growth and market conditions.

3. What is the current share price of Boston Bio Systems Ltd ? ›

As of 26-12-2025 the share price for Boston Bio Systems Ltd. is 6.93 on the NSE (Note: Prices are dynamic and update frequently during market hours).

4. What is the 52-week high and low of Boston Bio Systems Ltd ? ›

The 52-week high and low of Boston Bio Systems Ltd share price is ₹ 6.36 - ₹ 22 as of 26-12-2025 .
PL Ringside View

Our fireside chat series where industry experts and top management share valuable insights for our clients

Youtube

Mark Mobius on India’s Growth, Global Markets, and Investment Opportunities

Youtube

₹100 cr net profit in 7-12 months | Anjali Nashier, Revolt Motors

Youtube

India's Path to Energy Security | Dr. Praveer Sinha, MD & CEO, Tata Power

  • PL Capital Logo

  • Regd. Office : 3rd Floor, Sadhana House,
    570, P. B. Marg, Behind Mahindra Tower,
    Worli, Mumbai - 400 018, India

    View on Google Maps

  • Tel. : 02266322222

    Call us

Prabhudas Lilladher Private Limited | CIN: U67190MH1983PTC029670 | Registered Office Address: 3rd Floor, Sadhana House, 570, P.B. Marg, Worli, Mumbai – 400018, Maharashtra, India | SEBI Registration Details: Stock Broking: INZ000196637 [Membership Codes: NSE – 05977; BSE – 564; MCX – 40690] | Depository Participant: IN-DP-439-2019 [DP Codes: CDSL – 12011300; NSDL – IN303868 | Portfolio Management: INP000009001| Research Analyst: INZ000000271 | Investment Advisors: INA000018267 [BSEASL Membership Code: BASL2042] | AMFI ARN: 3276 | Compliance Officer: Mrs. Snehal Kathrani; Tel: 02266322420; email: co@plindia.com | For any Grievance/ Dispute: Stock Broking; email: grievance-br@plindia.com; Tel: 02266322366; Depository Participant; email: grievance-dp@plindia.com; Tel: 02266322452; Portfolio Management; email: grievance-pms@plindia.com; Tel: 02266322350.

To register your grievance on SCORES log onto: https://scores.gov.in/scores/Welcome.html. Register on SCORES portal. Mandatory details for filing complaints on SCORES: Name, PAN, Address, Mobile Number, Email ID

To register your grievance on Smart ODR Portal log onto: Online Dispute Resolution Portal (ODR Portal).

Standard Disclaimers: (a) Investment in securities market are subject to market risks, read all the related documents carefully before investing. (b) Brokerage will not exceed the SEBI prescribed limits. (c) Registration granted by SEBI, membership of BASL (in case of IAs) and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

The brand name and Logo ‘PL Capital’ are the registered trademarks of Prabhudas Lilladher Advisory Services Private Limited which is the holding company of Prabhudas Lilladher Group of Companies .

Prabhudas Lilladher Private Limited is not associated with any unregulated platform which claims performance/return for algorithmic strategy for trading. Trading with unregulated platforms for algorithmic strategy shall be at your own risk and Prabhudas Lilladher Private Limited or its affiliates shall not be liable for the same.

Risk Disclosure on Derivatives: (a) 9 out of 10 individual traders in equity futures and options segment, incurred net losses. (b) On an average, loss makers registered net trading loss close to ₹ 50,000 (c) Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs. (d) Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source